A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Kohli, Bhawna
- A one Year Study of the Adequacy of Primary Prophylaxis in Prevention of Glucocorticoid-induced Osteoporosis in Rural Western Uttar Pradesh
Authors
1 Department of Pediatrics, Saraswathi Institute of Medical Sciences, Hapur, Ghaziabad, U.P., IN
2 Department of Medicine, Saraswathi Institute of Medical Sciences, Hapur, Ghaziabad, U.P, IN
3 Department of Orthopedics, Saraswathi Institute of Medical Sciences, Hapur, Ghaziabad, U.P., IN
Source
Indian Journal of Public Health Research & Development, Vol 4, No 1 (2013), Pagination: 44-48Abstract
Introduction: Fragility fractures are well known&serious complication of long-term treatment with corticosteroids. Glucocorticoid-induced osteoporosis (GIOP) is characterized by rapid bone loss and increased fracture risk in the early stages of beginning of therapy and is amenable to proper preventive measures. Thus, glucocorticoid-induced bone loss should be treated aggressively. The aim of this study is to probe the adequacy of primary prophylaxis for glucocorticoid-induced osteoporosis (GIOP) in patients taking long-term steroids.
Methods: A retrospective study was conducted in our institute to assess treating doctor's awareness and preventive measures taken during treatment against GIOP. Hospital records of patients receiving > 7.5 mg/day of oral steroids for > 3 months were studied and relevant data was collected. Primary preventive measures instituted against GIOP were noted and the data was analyzed.
Results: Two hundred and three patients, 121 females and 82 males, fulfilling the inclusion criteria were included in this study. Of the 203 patients, 61 did not receive any prophylaxis, 97 received inadequate prophylaxis and only 45 were given appropriate prophylaxis.
Conclusions: The awareness about instituting primary preventive measures against GIOP among treating doctors is highly unsatisfactory. There is an urgent need to increase awareness and knowledge of GIOP management. There are effective strategies for prevention and treatment of GIOP&these should be used aggressively in such patients.
Keywords
Steroids, Glucocorticoid-Induced Osteoporosis (GIOP), Prophylaxis
References
- van Staa TP, Leufkens HGM, Cooper C. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 2002; 13:777-787.
- Compston J. Management of glucocorticoidinduced osteoporosis. Nat Rev Rheumatol 2010; 6: 82–88.
- Royal College of Physicians. Glucocorticoidinduced osteoporosis. Guidelines on prevention and treatment. Bone and Tooth Society of Great Britain, National Osteoporosis Society and Royal College of Physicians. London UK: Royal College of Physicians, 2002.
- Newman ED, Matzko CK, Olenginski TP, Perruquet JL, Harrington TM, Maloney-Saxon G, Culp T, Wood GC. Glucocorticoid-induced osteoporosis program (GIOP): a novel, comprehensive and highly successful care program with improved outcomes at 1 year. Osteoporos Int 2006; 17: 1428–1434.
- American College of Rheumatology 2010 Recommendations for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis: Arthritis Care & Research ,Vol. 62, No. 11, November 2010, pp 1515–1526.
- Evange Romas: Corticosteroid-induced osteoporosis and fractures: Aust Prescr 2008; 31:45-49
- Reid IR, Heap SW. Determinants of vertebral mineral density in patients receiving long term glucocorticoid therapy. Arch Intern Med 1990; 150:2545–2548.
- Dykman TR, Gluck OS, Murphy WA, Hahn TJ, Hahn BH. Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases. Arthritis Rheum 1985; 28: 361–368.
- Leufkens HGM, van Staa TP, Cooper C. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 2002; 13:777-787.
- Selby PL, Halsey JP, Adams KRH, et al. Corticosteroids do not alter the threshold for vertebral fracture. J Bone Miner Res 2000; 15: 952–956.
- Luengo M, Picado C, Del Rio L, Guanabens N, Montserrat JM, Setoain J. Vertebral fractures in steroid dependant asthma and involutional osteoporosis: a comparative study. Thorax 1991; 46: 803–806.
- Adler RA, Hochberg MC. Suggested guidelines for evaluation and treatment of glucocorticoidinduced osteoporosis for the Department of Veterans Affairs. Arch Intern Med 2003; 163: 2619–2624.
- National Osteoporosis Society. Guidelines on the prevention and management of corticosteroidinduced osteoporosis. London: NOS, 1998.
- Eastell R, Reid DM, Compston J, Cooper C, Fogelman I, Francis RM, et al. A UK consensus group on management of Glucocorticoid-induced osteoporosis. An update. J intern Med 1998; 244: 271–292.
- Saag KG, Shane E, Boonen S, Marín F, Donley DW, Taylor KA, et al. Teriparatide or Alendronate in glucocorticoid-induced osteoporosis. N Engl J Med 2007; 357: 2028–2039.
- Gera C, Vij AS. Glucocorticoid-induced osteoporosis: unawareness or negligence in India? Int J Rheum Dis 2009; 12: 230–233.
- Sadat-Ali M, Alelq AH, Alshafei BA, Al-Turki HA, Abujubara MA. Osteoporosis prophylaxis in patients receiving chronic glucocorticoid therapy. Ann Saudi Med 2009; 29: 215–218.
- Ungprasert S, Wangkaew S, Louthrenoo W. Physician’s awareness of the prevention of corticosteroid induced osteoporosis. J Med Assoc Thai 2007; 90: 59–64.
- Nagaraj Srinivasulu et al: Primary prophylaxis for steroid-induced osteoporosis .Indian Journal of Rheumatology, Volume 5, Issue 4,176-179 (December 2010)
- Bhatnagar T, Mishra CP, Mishra RN. Drug prescription practices: a household study in rural Varanasi. Indian J Prev Soc Med 2003; 34: 34–9.
- George R, Abraham R. Private health in India. Lancet 2002; 359: 1528.
- Hart SR, Green B. Osteoporosis prophylaxis during corticosteroid treatment: failure to prescribe. Post grad Med J 2002; 78: 242–243.
- A Study of Incidence of Fulminant Hepatic Failure in Paeditric Age Group and Knowledge, Behaviour & Attitude Regarding Etiology of Jaundice in Society
Authors
1 Department of Pediatrics, Saraswathi Institute of Medical Sciences, Anwarpur, Hapur, (Uttar Pradesh), IN
2 Department of Pathology, Saraswathi Institute of Medical Sciences, Anwarpur, Hapur, (Uttar Pradesh), IN
3 Department of Biochemistry, Saraswathi Institute of Medical Sciences, Anwarpur, Hapur, (Uttar Pradesh), IN
Source
Indian Journal of Public Health Research & Development, Vol 3, No 3 (2012), Pagination: 42-45Abstract
Object: To study the incidence and etiology of fulminant hepatic failure (FHF) in children and to study, attitude, behavior and knowledge regarding etiology and treatment of jaundice among the accompanying persons of cases of Jaundice.
Material & methods: The present study was conducted in the Department of Pediatrics, Saraswathi Institute of Medical Sciences (SIMS), Anwarpur, Hapur. 38570 children between 6 months to 18 years of age belonging to both rural and urban areas with signs and symptoms suggestive of liver disease and Children who fulfilled diagnostic criteria of FHF were included. Children were investigated for incidence and etiology of liver disease. A questionnaire was prepared to study the knowledge, attitude and behavior regarding etiology and treatment of jaundice among the accompanying persons of Jaundice Patients.
Result: Incidence of FHF was 1.4 per 1000 per year. Out of total 1010 jaundiced patients, incidence of FHF was 2.5%. Cases of FHF were maximum 61.1% in 5-15 year age group, Male: female ratio was almost equal in case of FHF (1.25:1). In our study etiological diagnosis was possible in 68.48% cases, out of which 61.08% were of viral etiology. 31.48%were idiopathic. Drug induced FHF was in 7.4%. Out of 1010 Jaundice patients, 370 patients (36.63%) were from urban area and 640 patients (63.36%) were from rural area. Commonest misconception was that the cause of hepatitis is super natural and they go to supernatural healers (Quacks) for treatment, 50% from urban area and 78.12% from rural area had this belief. They follow a special diet, they restrict protein, fat, Yellow Edible things like turmeric and not use full milk, in urban area 70.54% and In Rural area 84.37% had this belief. Knowledge and Awareness about immunisation, safe Injection and safe water was observed in accompanying persons of rural and urban area. it was found that there is less awareness in rural area then urban area. it was observed that there is significant co-relation between knowledge, attitude and behavior of public on the occurrence and complication of jaundice.
Conclusion: It is concluded that there is need to increase the public awareness by different educational programs regarding etiology of hepatitis and its prevention by immunisation for hepatitis A and B, use of safe injection, safe water and hygienic Sanitary habits. Early detection of liver disease and management of case by a competent doctor is the mainstay to decrease the mortality from jaundice. Type of Study: Prospective hospital based mortality.
Keywords
Jaundice, FHF, Hepatitis, ImmunizationReferences
- Nelson Textbook of pediatrics 18th edition volume 2 Page No. 1703-1705.
- Bradley DW, Maynard JE, Popper H et a! : Post transfusion non A non B hepatitis, Physiochemical property of two distinct agents. Infect, dis. 1983; 148: 254-265.
- Raju GS, Broor S. Singh V. and Mehta Sk: Fulminant viral Hepatitis : Indian experience Journal of Gastroenterology and Hepatology 1989; 4 : 161-165.
- Gimson AES, White YS, Eddleston ALWF, Williams R : Clinical and prognostic differences in Fulminant hepatitis type A, B, and non A non B. Gut 1983; 124 : 1194-1198.
- Poddar U, Thapa BR, Prasad A, Sharma AK, Singh K : Natural history and risk factors in fulminant hepatic failure. Arch Dis Child. 2002 Jul;87(1):54-56.
- M.D Yohannan, M. Arif, S. Ramia : Aetiology of Icteric Hepatitis and Fulminant Hepatic Failure in Children and the Possible Predisposition to Hepatic Failure by Sickle Cell Disease. Acta Paediatr Scand 1990;79(2):201-205.
- Thapa BR, Singh K, Singh V, Broor S, Nain CK : Pattern of hepatitis A & hepatitis B virus markers in cases of acute sporadic hepatitis & in healthy school children from North West India : Journal of Tropical Pediatrics, 1995; 41 : 328-329.
- Acute liver failure Gagan k sood, chief editor Julian katz, md medscape reference updated march 2011.
- Ronald A. Sacher, James W. Shih, and Robert H. Pureed : Hepatitis C Virus-Associated Fulminant Hepatic Failure. N Engl J Med 1996; 335:631-634.